That’s your opinion to think that the 28-60 day window
That’s your opinion to think that the 28-60 day window sailed. It seems simple enough for a regulatory agency that allowed an ongoing trial protocol to continue based on the original protocol. The PR stated 45 new patients already included. Maybe the new trial extension lists 60 day end point and it is retro to the beginning of the CD-12 trial just like the sailed 42 day end point was suppose to activate the retro capture of information to the beginning. Either way more information can be gathered from the continuance of the trial and only time will tell just how good our little drug could be as we move forward while having an EUA to progress our help in acquiring the needed information we need to show the world.
I like what Doc580 said about this being the prime time to give CYDY the EUA and continue trial information standards to use it. With an EAU Leronlimab becomes standard of care while achieving the statistical numbers to either stay as a EUA or not. This is the way of many drugs that have already trialed for covid. So why not us? especially in a pandemic as others have stated that even Janet Woodcock stated if there is no harm from the drug to establish the drug. Then approve the drug with a EUA to acquire statistical significance.
On another note:
If I was a short I would be worried about Monday and trying to short CYDY. I would remember that this drug is the only life saving drug for the critical indication of covid in the whole world that has shown proven life saving mortality. The stock just might go up and not down Monday morning in a squeeze. Especially if people from this board go to Reddit and make known that CYDY has had significant results and is awaiting a future EUA but the shorts like Adam F is crying wolf and lying yet again and starting a short attack for Monday morning. It’s not wise when you announce a short attack so early over a weekend and you allow a lot of time for people to get their plan together to squash a short attack. CYDY deserves this type of protection come Monday and the people of Reddit might just get motivated to help knowing what an ass Adam F really is. I might have to join Reddit tomorrow to just shake up that squeeze plan just a little more. Any help from this board to rally Reddit tomorrow and Sunday would be welcome. So JOIN REDDIT tomorrow if you haven’t already to progress protecting CYDY and potential lives saved around the world with Leronlimab. Do your part to screw Adam F once and for all. Reddit already screwed Adam Left and he stopped the shorting or so he said. Now it’s time to screw the other Adam.
6
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking Down the TRANSFORM II Trial Innovation never rests, folks, especially when it comes to treating coronary artery disease. Right on cue, the TRANSFORM II trial's results have hit the airwaves, marking a significant milestone with its implant-free MagicTouch Sirolimus-Coated Balloon (SCB) strategy. Getting the Lay of the Land This wasn't just some backyard...
Continue Reading
An Invincible Maritime Shield When it comes to maritime intelligence, Windward just pulled a fast one. In a market where staying ahead of the game is like playing three-dimensional chess, they've snatched up Azimut.ai. This ain't some small fry; it's a visual intelligence firm poised to shore up Windward's grip on the elusive maritime world. Charting New Waters with...
Continue Reading
Enterprise Networking's Growth Trajectory When the digits start rolling in at a compound annual growth rate of a neat 10.1%, you know there's a story worth watching. This tale of enterprise networking gaining traction is a head-turner, anticipated to soar from $134.59 billion in 2026 to a hefty $239.92 billion by 2032. Hold onto your hats—there's a storm of change...
Continue Reading
Florida Properties: The Buried Risk in Flood Zones If you’re dreaming of palm trees and sandy beaches, don't let flood zones turn that dream into a nightmare. It’s not all sunshine and rainbows when it comes to buying real estate in Florida, as it turns out—flood zones are lurking, and the devil's in the details. Understanding FEMA Flood Maps First off, these FEMA...
Continue Reading
Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...
Continue Reading
When Dodge decides to hit the track running, they mean it. They're cranking the engines and returning to the NASCAR Cup Series after years in the shadows. This isn't just about going fast; it's about redefining speed on the stock car circuit and maybe even the market tickers. Revving an Old Engine for a New Race Let's get this out there: Dodge pulling a U-turn back into...
Continue Reading
Another year, another feather in the cap for Tampa General Hospital (TGH). This academic health system has grabbed the spotlight once again by securing top rankings in Newsweek's 2027 America's Best-in-State Hospitals list. You have to hand it to them; they've been the reigning champions in the Tampa Bay region every single year since these rankings kicked off. If you...
Continue Reading
Recognition from Alma Mater Puts a Bow on a Storied Career When someone ventures out into the world and leaves a mark across continents, it’s a remarkable feat. It’s even more heartening when the place that helped shape them gets to extend a nod of recognition. Dr. Charles Huang, the mastermind behind Pasaca Capital, just unwound a new layer to his multicolored life...
Continue Reading
Dark Horse Cranes: A Rising Player in Texas Midland, Texas just got hotter, and it’s got nothing to do with the sun. Dark Horse Cranes LLC is ramping up operations across the Permian Basin and digital infrastructure markets, marking its debut with a hefty $5.6 million in contract awards. Not too shabby for just 90 days since launch. These contracts throw five of their...
Continue Reading
Here's a head-scratcher for you: Atlanta just cranked out apartment buildings like they were goin' outta style, yet folks with cash in hand can't get a foot in the door. With a whopping 10.9% vacancy rate, you'd think they'd be rolling out the welcome mat. But oh no, what's actually playing gatekeeper is our ol' buddy, the credit score. Plenty of Apartments, Not Enough...
Continue Reading
Top 5 Most Recently Viewed Articles
Faith and Leadership Converge at Turning Point USA Women's Summit Gotta wonder what makes the news tick these days. The Turning Point USA Women's Leadership Summit, set for June 5 to 7, 2026, in San Antonio, Texas, is sealing its presence on the airwaves by streaming live on the Great American Pure Flix platform. For those like me, who keep an eye on how entertainment...
Continue Reading
A Look at the Rapid Growth of American Express Stock American Express (AXP) has established itself as a strong performer in the competitive financial services industry, demonstrating astonishing growth over the last 10 years. With an impressive annualized return rate of 14.47%, it has outperformed the market by 3.31%. Currently, the company boasts a substantial market...
Continue Reading
Vivos Inc. Expands Global Presence Vivos Inc. recently announced a significant development that highlights their commitment to international business expansion. The company's board has authorized the establishment of a wholly owned subsidiary in India, a strategic move aimed at enhancing their global operations. Formation of Vivos Scientific India LLP The new subsidiary...
Continue Reading
Elliott Investment Management Requests Special Meeting Elliott Investment Management has taken a significant step by informing Southwest Airlines (NYSE: LUV) of its intention to request a special shareholder meeting. This development, reported by Bloomberg News, highlights the hedge fund's growing concerns regarding the airline’s current leadership. Motivation Behind...
Continue Reading
Sodexo's Share Buyback Transactions Overview In November, Sodexo engaged in a significant share buyback program that showcased its commitment to enhancing shareholder value. As one of the leading companies in the industry, Sodexo has been authorized by its Shareholders’ Meeting to repurchase its own shares as part of a strategic initiative. This article delves into...
Continue Reading